Exhibit 99.1
For Immediate Release
ENCORE MEDICAL GETS STOCKHOLDER
APPROVAL OF AGREEMENT WITH BLACKSTONE CAPITAL PARTNERS TO GO
PRIVATE FOR $6.55 PER SHARE
November 2, 2006 Austin, Texas,
— Encore Medical Corporation (“Encore”) (Nasdaq:
ENMC) today announced that at a special meeting of its
stockholders, its stockholders voted to adopt the definitive merger
agreement with a company newly formed and controlled by Blackstone
Capital Partners V L.P. (“Blackstone”) in a going
private transaction. The parties intend to consummate the
transaction on November 3, 2006. After the consummation of
the transaction, Encore’s common shares will no longer trade
on the NASDAQ Global Market.
Under the terms of the merger
agreement, Encore’s stockholders will receive $6.55 in cash
for each share of Encore common stock they hold. Encore has
appointed Wells Fargo Bank, N.A. as the agent for payment of the
merger consideration upon consummation of the
transaction.
ABOUT ENCORE MEDICAL
CORPORATION
Encore Medical Corporation is a
diversified orthopedic device company with leading positions in
many of the markets in which it competes. We develop,
manufacture and distribute a comprehensive range of high-quality
orthopedic devices used for rehabilitation, pain management and
physical therapy. We also develop, manufacture and distribute a
comprehensive suite of surgical reconstructive implant products. We
believe that we are one of a few orthopedic devi
